Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Auris Medical Holding AG

NASDAQ: EARSHealthcare / Biotechnology / Switzerland
0.51-0.04-7.27%Vol 1 164 9571Y Perf -87.51%
Dec 10th, 2018 15:30
BID0.51 ASK0.52
Open0.55 Previous Close0.55
Pre-Market0.54 After-Trading0.56
 -0.01 -1.82%  0.01 1.82%
Target Price
2.50 
Analyst Rating
— 0.00
Potencial %
390.20 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)3 
Earnings Rating
Neutral
Price Range Ratio 52wk %
4.40 
Earnings Date
15th Nov 2018

Today's Price Range

0.510.55

 

52wk Range

0.236.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-23.61%
3 Months
92.98%
6 Months
-54.55%
1 Year
-87.51%
3 Years
-98.22%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
EARS0.51-0.0400-7.27
AAPL169.390.90000.53
GOOG1 042.515.93000.57
MSFT107.402.58002.46
XOM76.31-1.3300-1.71
WFC48.94-1.3200-2.63
JNJ145.33-0.1000-0.07
FB142.535.11003.72
GE6.89-0.1200-1.71
JPM101.43-1.8600-1.80
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.80
Current Ratio
0.90
Long Term Debt to Total Capital
0.59
Total Debt to Equity
2.23
Interest Coverage
-8.10
Leverage Ratio -6.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
6.52
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-1.00
Cash Flow Per Share
-1.89
Price to Tangible Book
-23.53
Book Value per Share
-0.02
Enterprise Value (in ths.)
14 634
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-99.22
ROE last 12 Months
2 036.61
Return on Assets (5Y Avg)
-153.67
ROA last 12 Months
-80.26
Return on Capital (5Y Avg)
-81.19
ROC last 12 Months
-284.12
Return on invested Capital Q
-40.32
Return on invested Capital Y
-132.42
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.14-
Q04 2017--1.01-
Q03 2017-2.00-1.5025.00
Q02 2017-2.10-1.2042.86
Q01 2017-0.10-0.22-120.00
Q04 2016-0.22-0.1627.27
Q03 2016-0.28-0.2317.86
Q02 2016-0.26-0.260.00
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.200.00-
12/2017 QR-0.140.00-
12/2018 FY-0.42--
12/2019 FY-0.31--
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 164 957
Shares Outstanding (in ths.)6 120
Trades Count1 400
Dollar Volume605 906
Avg. Volume2 370 670
Avg. Weekly Volume1 865 250
Avg. Monthly Volume2 721 282
Avg. Quarterly Volume7 506 184

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

57%43%

Bearish Bullish

71%29%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News